Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Neptune Technologies & Bioressources Inc T.NTB

Sector: Healthcare | Sub-Sector: Biotechnology

Neptune Technologies & Bioressources Inc is a biotechnology company engaged in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids.
Price: $2.20 | Change: +$0.05 | %Change: +2.33%
Volume: 23,889 | Day High/Low: 2.22/2.14 | 52 Week High/Low: 4.00/1.26
View modes: 
3 stars

RE:RE:Neptune Launches NKO Focus backed by clinical data

Maybe management needs to start taking the Focus product - maybe communication and results would improve. LOL seriously guys get your stuff together and get this sick puppy moving up the stock charts!  rate and reply
5 stars

RE:Neptune Launches NKO Focus backed by clinical data

All of that is good except we still don't know where to get any of the new products at retail level so this critical news release is taking a lot longer then we'd like to see.. I am a consumer of...read more
3 stars

RE:Neptune Launches NKO Focus backed by clinical data

Good to know!!!! Where can it be bought??? Who knows that this product is on the market??? No advertising.....no offical launch. As usual....product just fell out of the sky!!!! LOL  rate and reply
5 stars

Neptune Launches NKO Focus backed by clinical data

http://www.nutraingredients-usa.com/Suppliers2/Neptune-launches-NKO-Focus-backed-by-clinical-data/?utm_source=newsletter_daily&utm_medium=email&utm_campaign=16-Dec-2014&c...read more
0 stars

news

When are we expecting some news .I bought some shares a month ago looking to add next week looks like good  support here. Also a stock i hold patient home care is heading up  i have it at .28 .Looks...read more
2.5 stars

RE:Holiday spirit is alive and well

Tax loss selling should end tomorrow. Hopefully the new CEO can bring a positive outcome - he hopefully understands the importance of communication and delivery on promises. Maybe further change...read more
0 stars

Holiday spirit is alive and well

Nice to see goodwill to all at this time of year on this board, brought to you by 7+ years of investor disappointment. I will predict another few days of tax loss selling (for I think 5 of the last 7...read more
3.5 stars

RE:RE:RE:RE:RE:Still a sad state of affairs

Removed from the board ? For calling you out on being a basher pathetic losers who's intentions are to discredit this stock and its ability to be a success HAHA I think not  rate and reply
2.5 stars

RE:RE:RE:RE:Still a sad state of affairs

I hope you will be removed from this board !!!!  rate and reply
3 stars

RE:RE:RE:Still a sad state of affairs

the most comical part is that these LOSERS actually think what they post matters and makes a difference / has an affect on this stock... which is does now. For me its just enjoyable to call you for...read more
3.5 stars

RE:RE:Still a sad state of affairs

The ONLY sad state of affairs around here is when BERGLAY and MORNINGSTAR open there fat pathetic mouths with useless drivel trying to bash this stock.. You continuosly come around here trying to make...read more
2 stars

RE:Still a sad state of affairs

if this would be a privat company, they would be out of business long time ago!!! They enjoy their paycheques, yet the investors in this mediocre outfit have not seen a penny yet!!!  rate and reply
2 stars

Still a sad state of affairs

The theme of most here - 2015 will be the year. It's pathetic that the sole reason for the share price activity of late has been tied to Alex Ruus' appearance onBNN.  ACasti promised full results by...read more
0.5 stars

RE:RE:RE:RE:RE:Moving sideways

The way I see is that Acasti's management doesn't want to communicate with the investor. I wanted to know the reason that the sales volumn of Onemia disappeared, but no answer, There hasn't been  a...read more
0 stars

RE:RE:RE:RE:RE:Moving sideways

Capre beats them all. Phase 3 will be a go. I'm thinking that we partner with someone for it or get taken out. I don't think we'll make the same mistake Amarin made. Who wouldn't take out a drug such...read more
0 stars

RE:RE:RE:RE:Moving sideways

Some people seem excited about the Capre's full results , lots of movement on both Acasti and Neptune shares over past few days.   I think phase 3 is a go and Capre is superior to vascepa in all...read more
0 stars

RE:RE:RE:Moving sideways

Yes, they will but I don't believe it will be in the form of a regular press release. I believe it will either be web-site or sedar.  rate and reply
0 stars

RE:RE:Moving sideways

They did say that they expect the full results by end of 2014 , but did not mention that they will be released. Also on Acasti's website I don't see any upcoming scientific meetings ... They will have...read more
0 stars

RE:Moving sideways

I've asked that question several times now from J.R. and the answer I get is that there will be no official news release about the full results. They will be presented at the next science forum to...read more
5 stars

Moving sideways

Capre's full results should be out next week. Not much else going on till 2015, but SP seems to be buildig a base here for the next leg up. Hopefully Capre's news will provide a nice X-Mas gift for...read more

Featured News Links